Literature DB >> 28718445

Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.

Evgeniy B Eruslanov1, Sunil Singhal2, Steven M Albelda3.   

Abstract

Many types of cancer recruit neutrophils that could have protumor or antitumor effects on tumor development. Numerous findings in murine models suggest a predominantly protumoral role for neutrophils in cancer development. However, there are fundamental differences between mouse and human tumors in the evolution of tumors, genetic diversity, immune response, and also in the intrinsic biology of neutrophils that might have a profound impact on tumor development and the function of these cells. A crucial difference is that the majority of mouse tumor models lack the prolonged initial phases of multistage tumor evolution present in humans when antitumoral mechanisms are activated. In this review, we discuss the challenges specific to cross-species extrapolation of neutrophil function during mouse versus human tumor development.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28718445      PMCID: PMC5518602          DOI: 10.1016/j.trecan.2016.12.006

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  98 in total

1.  Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes.

Authors:  N S Potter; C V Harding
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

2.  Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.

Authors:  Trine O Jensen; Henrik Schmidt; Holger J Møller; Frede Donskov; Morten Høyer; Pia Sjoegren; Ib J Christensen; Torben Steiniche
Journal:  Cancer       Date:  2011-09-22       Impact factor: 6.860

Review 3.  Lost in translation: animal models and clinical trials in cancer treatment.

Authors:  Isabella Wy Mak; Nathan Evaniew; Michelle Ghert
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

Review 4.  Structures of human proteinase 3 and neutrophil elastase--so similar yet so different.

Authors:  Eric Hajjar; Torben Broemstrup; Chahrazade Kantari; Véronique Witko-Sarsat; Nathalie Reuter
Journal:  FEBS J       Date:  2010-05       Impact factor: 5.542

Review 5.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

6.  Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression.

Authors:  Inbal Mishalian; Rachel Bayuh; Liran Levy; Lida Zolotarov; Janna Michaeli; Zvi Gregorio Fridlender
Journal:  Cancer Immunol Immunother       Date:  2013-10-04       Impact factor: 6.968

Review 7.  Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.

Authors:  Katrin Moses; Sven Brandau
Journal:  Semin Immunol       Date:  2016-04-07       Impact factor: 11.130

Review 8.  Neutrophil--mediated cytotoxicity against tumour cells: state of art.

Authors:  F Dallegri; L Ottonello
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1992       Impact factor: 4.291

Review 9.  Neutrophil extracellular traps in cancer progression.

Authors:  Jonathan Cools-Lartigue; Jonathan Spicer; Sara Najmeh; Lorenzo Ferri
Journal:  Cell Mol Life Sci       Date:  2014-07-29       Impact factor: 9.261

Review 10.  Distinct Functions of Neutrophil in Cancer and Its Regulation.

Authors:  Zvi Granot; Jadwiga Jablonska
Journal:  Mediators Inflamm       Date:  2015-11-16       Impact factor: 4.711

View more
  46 in total

Review 1.  Neutrophils in the Tumor Microenvironment.

Authors:  Lingyun Wu; Sugandha Saxena; Rakesh K Singh
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  How little is known about the role of human FOXP3+ Tregs in tumors.

Authors:  Tatiana Akimova; Wayne W Hancock
Journal:  Expert Opin Ther Targets       Date:  2018-07-19       Impact factor: 6.902

3.  Neutrophil specific granule and NETosis defects in gray platelet syndrome.

Authors:  Cathelijn E M Aarts; Kate Downes; Arie J Hoogendijk; Evelien G G Sprenkeler; Roel P Gazendam; Rémi Favier; Marie Favier; Anton T J Tool; John L van Hamme; Myrto A Kostadima; Kate Waller; Barbara Zieger; Maaike G J M van Bergen; Saskia M C Langemeijer; Bert A van der Reijden; Hans Janssen; Timo K van den Berg; Robin van Bruggen; Alexander B Meijer; Willem H Ouwehand; Taco W Kuijpers
Journal:  Blood Adv       Date:  2021-01-26

4.  Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.

Authors:  Bhagelu R Achyut; Hao Zhang; Kartik Angara; Nahid F Mivechi; Ali S Arbab; Lan Ko
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

Review 5.  The complexity of neutrophils in health and disease: Focus on cancer.

Authors:  Silvia Carnevale; Somayehsadat Ghasemi; Anna Rigatelli; Sebastien Jaillon
Journal:  Semin Immunol       Date:  2020-09-18       Impact factor: 11.130

6.  Challenges and Controversies Concerning Neisseria gonorrhoeae-Neutrophil Interactions in Pathogenesis.

Authors:  Alison K Criss; Caroline A Genco; Scott D Gray-Owen; Ann E Jerse; H Steven Seifert
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

Review 7.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

Review 8.  Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy.

Authors:  Maria Teresa Masucci; Michele Minopoli; Maria Vincenza Carriero
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

Review 9.  Myeloid-derived suppressor cells coming of age.

Authors:  Filippo Veglia; Michela Perego; Dmitry Gabrilovich
Journal:  Nat Immunol       Date:  2018-01-18       Impact factor: 25.606

Review 10.  Neutrophils as emerging therapeutic targets.

Authors:  Tamás Németh; Markus Sperandio; Attila Mócsai
Journal:  Nat Rev Drug Discov       Date:  2020-01-22       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.